Screening/Prevention Prostate Cancer


Pass it On: It’s National Prostate Cancer Awareness Month (September 5, 2016)

Prostate cancer is the most common type of cancer in men other than skin cancer, and the second leading cause of death.  The American Cancer Society estimates that in 2015 there will be approximately... Continue Reading

New Survey Reveals that Prostate Cancer Impacts Sex Lives More than Any Other Aspect of Patients’ Lives (September 11, 2014)

Washington, DC (September 8, 2014) – A recent survey conducted by ZERO – The End of Prostate Cancer and Ferring Pharmaceuticals Inc. aimed to uncover the impact of prostate cancer on patients, their... Continue Reading

September Brings Awareness to Prostate Cancer (September 4, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of prostate cancer programs for national prostate cancer awareness month.  Prostate cancer is the most frequently diagnosed... Continue Reading

Prostate Cancer Screening Can Take a Toll on Quality of Life (December 19, 2012)

Screening for prostate cancer carries some risks and can affect quality of life. Considering these risks is important when making the decision about whether to be screened. The results of a study that... Continue Reading

PSA Testing May Be Appropriate for Some Men (July 25, 2012)

The American Society of Clinical Oncology (ASCO) has released a Provisional Clinical Opinion (PCO) suggesting that that men with a longer life expectancy—those with at least 10 more years to live—discuss... Continue Reading

Side Effects of Prostate Cancer Treatment Persist Long-Term (July 5, 2012)

Men who are treated for prostate cancer may continue to suffer from side effects 10 years after treatment, according to the results of a study published in the Journal of Clinical Oncology. Each year in... Continue Reading

Number of Cancer Survivors Will Grow to 18 Million by 2022 (June 25, 2012)

There will be nearly 18 million cancer survivors in the United States by 2022, according to a report by the American Cancer Society and the National Cancer Institute: Cancer Treatment & Survivorship... Continue Reading

Prostate Screening Not Recommended for Older Men (June 1, 2012)

The U.S. Preventive Services Task Force (USPSTF) recently drafted a grade D recommendation against prostate-specific antigen (PSA) screening for prostate cancer; however, it is unclear how this will affect... Continue Reading

Vitamin E Supplementation Appears to Increase Risk of Prostate Cancer (May 11, 2012)

The final analysis of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) indicated that vitamin E increased the risk of developing prostate cancer in otherwise healthy men by 17% when compared... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading

Gene Mutation Linked with Increased Risk of Prostate Cancer (January 17, 2012)

Researchers have identified a rare, inherited gene mutation that appears to substantially increase the risk of prostate cancer. These results were published in the New England Journal of Medicine. For... Continue Reading

Study Finds No Evidence That PSA Screening Reduces Prostate Cancer Mortality (January 10, 2012)

Updated results from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial show no evidence that annual screening with the prostate-specific antigen (PSA) test reduces deaths from prostate... Continue Reading

Vitamin E Supplements Increase Prostate Cancer Risk (October 20, 2011)

The results of a large, randomized trial suggest that taking daily vitamin E supplements may increase a man’s risk of prostate cancer. These results were published in the Journal of the American Medical... Continue Reading

LANDMARK LA BUILDINGS GO BLUE FOR NATIONAL PROSTATE CANCER AWARENESS MONTH (September 6, 2011)

FOR IMMEDIATE RELEASE Contact Information Cara Lasala Senior Public Relations Specialist 310.570.4727 (Direct) clasala@pcf.org LANDMARK LA BUILDINGS GO BLUE FOR NATIONAL PROSTATE CANCER AWARENESS... Continue Reading

Urine Test May Help Guide Prostate Biopsy Decisions (August 9, 2011)

An investigational urine test may help men with an elevated prostate-specific antigen (PSA) level decide whether a prostate biopsy is necessary. These results were published in Science Translational Medicine. Men... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s... Continue Reading

No Clear Role for Selenium in Cancer Prevention (May 17, 2011)

Some studies have suggested that people with higher selenium levels have a lower risk of certain types of cancer; a review conducted by the Cochrane Collaboration, however, found no clear evidence that... Continue Reading

Testosterone May Be Safe for Some Men with Prostate Cancer (April 27, 2011)

Testosterone therapy (used to treat symptoms of testosterone deficiency) may not worsen prostate cancer in selected men undergoing active surveillance for early-stage disease. These results were published... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS